Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Replimune Group, Inc. | Chief Medical Officer | Common Stock | 110K | $1.18M | $10.78 | Nov 18, 2024 | Direct |
Replimune Group, Inc. | Chief Medical Officer | Employee Stock Option (right to buy) | 80K | Apr 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
REPL | Replimune Group, Inc. | Nov 18, 2024 | 1 | -$78.1K | 4 | Nov 20, 2024 | Chief Medical Officer |
REPL | Replimune Group, Inc. | Jun 7, 2024 | 1 | -$119K | 4 | Jun 10, 2024 | Chief Medical Officer |
REPL | Replimune Group, Inc. | May 16, 2024 | 1 | -$41.2K | 4 | May 20, 2024 | Chief Medical Officer |
REPL | Replimune Group, Inc. | Apr 1, 2024 | 2 | $0 | 4 | Apr 3, 2024 | Chief Medical Officer |
REPL | Replimune Group, Inc. | Nov 16, 2023 | 1 | -$79.9K | 4 | Nov 17, 2023 | Chief Medical Officer |
REPL | Replimune Group, Inc. | May 16, 2023 | 1 | -$13.9K | 4 | May 18, 2023 | Chief Medical Officer |
REPL | Replimune Group, Inc. | Apr 1, 2023 | 2 | $0 | 4 | Apr 4, 2023 | Chief Medical Officer |
REPL | Replimune Group, Inc. | Dec 1, 2022 | 2 | $0 | 4 | Dec 5, 2022 | Chief Medical Officer |
REPL | Replimune Group, Inc. | Dec 1, 2022 | 0 | $0 | 3 | Dec 5, 2022 | Chief Medical Officer |